1. J. G.
Hardman
, L. E.Limbird and A. G.Gilman, Goodman & Gilman's – The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, 9th edn, 1996
2. Crystal Phend, Staff Writer, FDA Approves Triple-Drug Antihypertensive Polypill, Med Page Today, Washington, http://www.medpagetoday.com/ProductAlert/Prescriptions/14032
3. Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER), Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) Tablets, http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm262227.htm
4. H. C. T. Exforge, Rx List, http://www.rxlist.com/exforge-hct-drug.htm
5. Development and Validation of HPLC Method for Simultaneous Determination of Amlodipine, Valsartan, Hydrochlorothiazide in Dosage Form and Spiked Human Plasma